STING (stimulator of interferon genes) inhibitors have been shown to help T cells thrive and work synergistically with other cancer therapies, so new trials are underway to test whether they can be used to improve response in certain patients.
Original Article: Buzz Continues Over STING Inhibitors
NEXT ARTICLE